Nordic Outposts

Conversations and updates from Nordic founders and leaders building abroad.

← Home
IQM rings the bell at Nasdaq - one of fifteen Nordic listings on a US exchange this decade
IQM rings the bell at Nasdaq - one of fifteen Nordic listings on a US exchange this decade
New YorkSignals27 Aug 2026

What a Decade of IPOs in the US Reveal About Nordic Industrial Strengths

Every Nordic country carries a reputation for a specific industry: consumer tech, biotech, heavy industrials. A first look at a decade of US stock listings puts real numbers behind that reputation. Fifteen Nordic-founded companies have listed on a US exchange since 2016, raising roughly $6 billion combined. Sweden accounts for six of the fifteen and well over half the capital, led by Oatly ($1.4B) and Klarna ($1.4B). Denmark follows closely with five listings. Norway has two; Finland and Iceland one, respectively.

Looking closer at this data uncovers a genuine national pattern. Sweden's listings skew consumer-facing with food, fintech, EVs. Denmark's five are dominated by biotech. Norway's two are industrial: offshore drilling and battery manufacturing. Finland's sole completed entry, IQM Quantum Computers, is deep tech; Iceland's, Alvotech, is biosimilars.

Companies choose a US listing for different reasons: raising fresh capital directly, as Klarna and Oatly did; adding a US listing later for a deeper specialized investor base, as Genmab, Calliditas, and Zealand Pharma all did for biotech-specific capital; combining with an already-listed US company, as Cadeler did with Eneti; or a SPAC merger, faster than a traditional IPO, used by Polestar, FREYR, Alvotech, and IQM. Some companies instead stay listed at home and market shares to US institutional buyers without an actual US listing at all, and not reflected in the data above, since no US exchange listing occurs.

Outcomes since listing vary as widely as the reasons for it. Olink was acquired by Thermo Fisher, a clean exit; Hemab is up sharply since its 2026 debut; Genmab and Calliditas remain independently listed and growing. FREYR pivoted, relocated to the US, and rebranded as T1 Energy, while Polestar's stock has traded well below its SPAC-era valuation. Zealand Pharma tried the US listing route and reversed it, voluntarily delisting its ADSs in 2022 to consolidate back in Copenhagen. IQM took a different path, choosing to stay headquartered in Espoo and dual-list rather than relocate.

Three more Nordic companies are already in motion toward the same decision. Oura, following its 2026 restructuring, has confidentially filed for a US IPO. Joe & the Juice's owner General Atlantic has held early discussions with advisers. And Spinnova, a Finnish materials technology company already listed in Helsinki, confidentially filed for a US dual listing this August, targeting at least $15 million. Worth watching alongside a broader, still-unconfirmed question of how this decade's public capital compares to what several of these same companies raised privately beforehand.

If we've missed a listing or gotten a detail wrong, let us know, we'd like to keep this accurate as more Nordic companies consider the path to public.

Source: Company filings and press releases, Nordic Outposts analysis